Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

36. Nguyen A L, Johnson P N, Neely S, Hughes K M, Sekar K C, Welliver, Sr R C, Miller J L. Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 372-378

37. Salemi L A, Sahlstrom A L, Lim S Y, Johnson P N, Dannaway D, Miller J L. Evaluation of the Use of Caffeine Citrate Maintenance Doses 5 mg/kg/day in Preterm Neonates for Apnea of Prematurity. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 608-614

38. Johnson P N, Shaddix B P, Weller B M, Oschman A, George D, Neely S, Miller J L. Exploring Residency Program Directors, Preceptors, and Residents' Intentions to Participate in Multicenter Pediatric Pharmacy Resident Research Projects. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 708-717

39. Miller J L, Lewis T V, Walling J, O'Donnell A, Neely S, Johnson P N. Publication Rates of Pediatric-Focused Resident Research Projects Presented at The Pediatric Pharmacy Association Bruce Parks Memorial Residency Showcase. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 163-171

40. Shaddix B P, Miller J L, Johnson P N. Letter to the editor rebuttal: Which PGY1 pharmacy residency is right for me? Advantages and disadvantages of pediatric-focused and traditional PGY1 pharmacy programs. Journal of Pediatric Pharmacology and Therapeutics. 2020; 25 : 531-533

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.


4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.


5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results